Elgohary N - Search Results

1

Protumorigenic role of Timeless in hepatocellular carcinoma.

Elgohary N, Pellegrino R, Neumann O, Elzawahry HM, Saber MM, Zeeneldin AA, Geffers R, Ehemann V, Schemmer P, Schirmacher P, Longerich T. Elgohary N, et al. Int J Oncol. 2015 Feb;46(2):597-606. doi: 10.3892/ijo.2014.2751. Epub 2014 Nov 14. Int J Oncol. 2015. PMID: 25405317

2

EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.

Pellegrino R, Calvisi DF, Neumann O, Kolluru V, Wesely J, Chen X, Wang C, Wuestefeld T, Ladu S, Elgohary N, Bermejo JL, Radlwimmer B, Zörnig M, Zender L, Dombrowski F, Evert M, Schirmacher P, Longerich T. Pellegrino R, et al. Among authors: elgohary n. Hepatology. 2014 May;59(5):1886-99. doi: 10.1002/hep.26954. Epub 2014 Mar 27. Hepatology. 2014. PMID: 24285179 Free PMC article.

3

Influence of occlusal reduction design on the fracture resistance and biomechanical behavior of endocrowns restoring maxillary premolars.

Abbas MH, Elerian FA, Elsherbiny AA, Elgohary NMM, Atout A. Abbas MH, et al. Among authors: elgohary nmm. BMC Oral Health. 2024 Jan 19;24(1):113. doi: 10.1186/s12903-023-03688-3. BMC Oral Health. 2024. PMID: 38243249 Free PMC article.

4

Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2.

Abd Elhameed AA, Ali AR, Ghabbour HA, Bayomi SM, El-Gohary NS. Abd Elhameed AA, et al. Drug Dev Res. 2023 Dec;84(8):1664-1698. doi: 10.1002/ddr.22109. Epub 2023 Sep 3. Drug Dev Res. 2023. PMID: 37661648

5

Design, synthesis, and evaluation of new benzimidazole‏ ‏‎thiourea ‎derivatives as antitumor agents.

Aboutaleb MH, El-Gohary NS, Ghabbour HA, El-Kerdawy MM. Aboutaleb MH, et al. Arch Pharm (Weinheim). 2023 Nov;356(11):e2300269. doi: 10.1002/ardp.202300269. Epub 2023 Aug 21. Arch Pharm (Weinheim). 2023. PMID: 37602810

6

New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study.

Mansour NI, El-Sayed SM, El-Gohary NS, Abdel-Aziz NI, El-Subbagh HI, Ghaly MA. Mansour NI, et al. Bioorg Chem. 2022 Oct;127:105966. doi: 10.1016/j.bioorg.2022.105966. Epub 2022 Jun 14. Bioorg Chem. 2022. PMID: 35728294

7

Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).

Shaheen MA, El-Emam AA, El-Gohary NS. Shaheen MA, et al. Bioorg Chem. 2020 Dec;105:104274. doi: 10.1016/j.bioorg.2020.104274. Epub 2020 Sep 12. Bioorg Chem. 2020. PMID: 33339080

8

New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation.

Warda ET, Shehata IA, El-Ashmawy MB, El-Gohary NS. Warda ET, et al. Bioorg Med Chem. 2020 Nov 1;28(21):115674. doi: 10.1016/j.bmc.2020.115674. Epub 2020 Jul 28. Bioorg Med Chem. 2020. PMID: 33065442

9

Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives.

Qandeel NA, El-Damasy AK, Sharawy MH, Bayomi SM, El-Gohary NS. Qandeel NA, et al. Bioorg Chem. 2020 Sep;102:103890. doi: 10.1016/j.bioorg.2020.103890. Epub 2020 May 4. Bioorg Chem. 2020. PMID: 32801081

10

1,4,5,6,7,8-Hexahydroquinolines and 5,6,7,8-tetrahydronaphthalenes: A new class of antitumor agents targeting the colchicine binding site of tubulin.

Shaheen MA, El-Emam AA, El-Gohary NS. Shaheen MA, et al. Bioorg Chem. 2020 Jun;99:103831. doi: 10.1016/j.bioorg.2020.103831. Epub 2020 Apr 12. Bioorg Chem. 2020. PMID: 32388203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page